Quality improvement guidelines for radiofrequency ablation of liver tumours

Laura Crocetti, Thierry De Baere, Riccardo Lencioni

Research output: Contribution to journalArticle

147 Citations (Scopus)

Abstract

The development of image-guided percutaneous techniques for local tumour ablation has been one of the major advances in the treatment of liver malignancies. Among these methods, radiofrequency ablation (RFA) is currently established as the primary ablative modality at most institutions. RFA is accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when liver transplantation or surgical resection are not suitable options [1, 2]. In addition, RFA is considered a viable alternate to surgery (1) for inoperable patients with limited hepatic metastatic disease, especially from colorectal cancer, and (2) for patients deemed ineligible for surgical resection because of extent and location of the disease or concurrent medical conditions [3]. These guidelines were written to be used in quality-improvement programs to assess RFA of HCC and liver metastases. The most important processes of care are (1) patient selection, (2) performing the procedure, and (3) monitoring the patient. The outcome measures or indicators for these processes are indications, success rates, and complication rates.

Original languageEnglish (US)
Pages (from-to)11-17
Number of pages7
JournalCardioVascular and Interventional Radiology
Volume33
Issue number1
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Quality Improvement
Guidelines
Hepatocellular Carcinoma
Liver
Neoplasms
Physiologic Monitoring
Liver Transplantation
Patient Selection
Colorectal Neoplasms
Outcome Assessment (Health Care)
Neoplasm Metastasis
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Quality improvement guidelines for radiofrequency ablation of liver tumours. / Crocetti, Laura; De Baere, Thierry; Lencioni, Riccardo.

In: CardioVascular and Interventional Radiology, Vol. 33, No. 1, 02.2010, p. 11-17.

Research output: Contribution to journalArticle

Crocetti, Laura ; De Baere, Thierry ; Lencioni, Riccardo. / Quality improvement guidelines for radiofrequency ablation of liver tumours. In: CardioVascular and Interventional Radiology. 2010 ; Vol. 33, No. 1. pp. 11-17.
@article{356eb40a397c49d48b47ea32f2e9d302,
title = "Quality improvement guidelines for radiofrequency ablation of liver tumours",
abstract = "The development of image-guided percutaneous techniques for local tumour ablation has been one of the major advances in the treatment of liver malignancies. Among these methods, radiofrequency ablation (RFA) is currently established as the primary ablative modality at most institutions. RFA is accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when liver transplantation or surgical resection are not suitable options [1, 2]. In addition, RFA is considered a viable alternate to surgery (1) for inoperable patients with limited hepatic metastatic disease, especially from colorectal cancer, and (2) for patients deemed ineligible for surgical resection because of extent and location of the disease or concurrent medical conditions [3]. These guidelines were written to be used in quality-improvement programs to assess RFA of HCC and liver metastases. The most important processes of care are (1) patient selection, (2) performing the procedure, and (3) monitoring the patient. The outcome measures or indicators for these processes are indications, success rates, and complication rates.",
author = "Laura Crocetti and {De Baere}, Thierry and Riccardo Lencioni",
year = "2010",
month = "2",
doi = "10.1007/s00270-009-9736-y",
language = "English (US)",
volume = "33",
pages = "11--17",
journal = "CardioVascular and Interventional Radiology",
issn = "7415-5101",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Quality improvement guidelines for radiofrequency ablation of liver tumours

AU - Crocetti, Laura

AU - De Baere, Thierry

AU - Lencioni, Riccardo

PY - 2010/2

Y1 - 2010/2

N2 - The development of image-guided percutaneous techniques for local tumour ablation has been one of the major advances in the treatment of liver malignancies. Among these methods, radiofrequency ablation (RFA) is currently established as the primary ablative modality at most institutions. RFA is accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when liver transplantation or surgical resection are not suitable options [1, 2]. In addition, RFA is considered a viable alternate to surgery (1) for inoperable patients with limited hepatic metastatic disease, especially from colorectal cancer, and (2) for patients deemed ineligible for surgical resection because of extent and location of the disease or concurrent medical conditions [3]. These guidelines were written to be used in quality-improvement programs to assess RFA of HCC and liver metastases. The most important processes of care are (1) patient selection, (2) performing the procedure, and (3) monitoring the patient. The outcome measures or indicators for these processes are indications, success rates, and complication rates.

AB - The development of image-guided percutaneous techniques for local tumour ablation has been one of the major advances in the treatment of liver malignancies. Among these methods, radiofrequency ablation (RFA) is currently established as the primary ablative modality at most institutions. RFA is accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when liver transplantation or surgical resection are not suitable options [1, 2]. In addition, RFA is considered a viable alternate to surgery (1) for inoperable patients with limited hepatic metastatic disease, especially from colorectal cancer, and (2) for patients deemed ineligible for surgical resection because of extent and location of the disease or concurrent medical conditions [3]. These guidelines were written to be used in quality-improvement programs to assess RFA of HCC and liver metastases. The most important processes of care are (1) patient selection, (2) performing the procedure, and (3) monitoring the patient. The outcome measures or indicators for these processes are indications, success rates, and complication rates.

UR - http://www.scopus.com/inward/record.url?scp=77949275186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949275186&partnerID=8YFLogxK

U2 - 10.1007/s00270-009-9736-y

DO - 10.1007/s00270-009-9736-y

M3 - Article

C2 - 19924474

AN - SCOPUS:77949275186

VL - 33

SP - 11

EP - 17

JO - CardioVascular and Interventional Radiology

JF - CardioVascular and Interventional Radiology

SN - 7415-5101

IS - 1

ER -